The new guidelines will also require doctors to provide a written description of a patient’s symptoms and provide details about their symptoms before prescribing a medicine.
The guidelines are being developed as part of a campaign to make sure the guidelines are followed by all patients, said Dr. Michael DeMarco, an associate professor at the University of Colorado School of Medicine.
He said he hopes to see a change in how physicians and nurses interact.
“The whole idea is that the patient is being kept informed and the doctor is making sure that the doctor and nurse know what’s happening and are working collaboratively,” he said.
“I’m not a huge advocate of giving people all this information to be able to make the decisions that are right for them.
I think we have to give patients more of an opportunity to make those decisions for themselves.”
The guidelines, which were released in the United States on Monday, were also introduced in Canada and will be made available to other countries this year.
The changes come after a number of deaths in the U.S. and Canada have been linked to opioids.
In Canada, one of the country’s most deadly opioid-related deaths occurred in the first quarter of this year when an opioid overdose victim died in hospital after taking an overdose of a powerful painkiller.
In addition to the opioid prescribing guidelines, Canada’s new guidelines include a new mandatory 24-hour waiting period for prescriptions, a requirement to notify patients when a doctor or nurse prescribes a medicine, and a ban on selling or offering to sell controlled substances.